Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
POL-6 is a standardized polyherbal preparation composed of dried extracts from six medicinal plants: *Bacopa monnieri*, *Hypericum perforatum*, *Centella asiatica*, *Withania somnifera*, *Camellia sinensis*, and *Ocimum sanctum* in a specific ratio (2:1:2:2:1:2). It is primarily investigated for its therapeutic potential in treating ethanol withdrawal-induced anxiety and alcohol dependence. The preparation contains bioactive phytoconstituents such as withaferin A, quercetin, catechin, rutin, caffeic acid, and β-sitosterol. Mechanistically, POL-6 appears to normalize GABAergic neurotransmission by modulating the mRNA expression of GABAA receptor subunits in the amygdala and hippocampus, thereby exerting anxiolytic effects during alcohol withdrawal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on POL-6.